Analyst Sarah James has formally begun covering shares of Nashville's big three hospital operators as well as other prominent health care players. She rates both HCA Holdings and Community Health Systems at 'outperform,' saying investors will benefit from, among other things, the growth of HCA's Parallon support services unit and CHS' potential for margin expansion. James isn't as bullish on the prospects of LifePoint Health, which she has given a 'neutral' rating.
Over at Goldman Sachs, analysts have launched coverage of Amsurg with a 'buy' rating and $81 target. That's 17 percent above where AmSurg (Ticker: AMSG) closed Wednesday trading.
Dickson Medical Associates will pay $500,000 in civil damages for distributing non-FDA approved drugs.
The U.S. Attorney for the Middle District of Tennessee alleges that a physician at Dickson Medical Associates obtained and prescribed non-FDA approved Aclasta from foreign sources and billed for it as Reclast, which is approved in the United States. The drugs are used to treat osteoporosis and bone damage.
"The Food, Drug and Cosmetic Act and its enacting regulations exist to ensure the safety and efficacy of prescription drugs sold within the United States," David Rivera, U.S. Attorney, said in a release. "The resolution set fourth in this settlement agreement should send a clear message that this office will diligently pursue any violations of those laws."
Two Texas investment firms have declared sizable stakes in local companies. First up, Vaughan Nelson Investment Management of Houston added to its stake in AmSurg late in 2014, finishing the year with more than 2.2 million shares, or 5.9 percent. Vaughan Nelson manages more than $6.6 billion. AmSurg shares (Ticker: AMSG) finished last week at $55.56 and have climbed 11 percent over the past three months.
Further up Interstate 45 in Dallas, Nokomis Capital filed papers to say it now owns almost 1.2 million shares, or 6.8 percent, of home goods retailer Kirkland's. The hedge fund, which was launched in 2008, manages almost $400 million. Kirkland's has been on a good sales and profits run of late, with its shares (Ticker: KIRK) having climbed 35 percent over the past three months.
POSTDATA: WARRANTY DEEDS